The latest closing stock price for Entero Therapeutics as of September 18, 2024 is 0.34.
An investor who bought $1,000 worth of Entero Therapeutics stock at the IPO in 2016 would have $-1,000 today, roughly -1 times their original investment - a -81.10% compound annual growth rate over 8 years.
The all-time high Entero Therapeutics stock closing price was 230159.98 on October 12, 2016.
The Entero Therapeutics 52-week high stock price is 14.51, which is 4167.6% above the current share price.
The Entero Therapeutics 52-week low stock price is 0.18, which is 47.1% below the current share price.
The average Entero Therapeutics stock price for the last 52 weeks is 3.68.
An investor who bought $1,000 worth of Entero Therapeutics stock at the IPO in 2016 would have $-1,000 today, roughly -1 times their original investment - a -81.10% compound annual growth rate over 8 years.
The all-time high Entero Therapeutics stock closing price was 230159.98 on October 12, 2016.
The Entero Therapeutics 52-week high stock price is 14.51, which is 4167.6% above the current share price.
The Entero Therapeutics 52-week low stock price is 0.18, which is 47.1% below the current share price.
The average Entero Therapeutics stock price for the last 52 weeks is 3.68.